Pharmacokinetics and Safety of a Single Dose of Stavudine (D4T) in Patients With Severe Hepatic Impairment.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.41.12.2793
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

Safety of High-Dose Daptomycin in Patients With Severe Renal Impairment

Therapeutics and Clinical Risk Management
2018English

The Pharmacokinetics and Safety of Darapladib in Subjects With Severe Renal Impairment

British Journal of Clinical Pharmacology
Pharmacology
2015English

Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2019English

Effect of Severe Renal Impairment on the Pharmacokinetics of Azimilide Following Single Dose Oral Administration

British Journal of Clinical Pharmacology
Pharmacology
2002English

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects With Severe Renal Impairment

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Murepavadin, a Novel Antipseudomonal Antibiotic: Pharmacokinetics, Tolerability and Safety in Subjects With Mild, Moderate, and Severe Renal Function Impairment

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Safety and Efficacy of Ibrutinib in a Patient With Severe Renal Impairment

Hematology Reports
Hematology
2017English

Combination Therapy With Stavudine (D4T), Didanosine (ddI), and Indinavir in HIV-Infected Children • 727

Pediatric Research
Child HealthPediatricsPerinatology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy